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resumo 
 
 
Candida albicans é um fungo polimórfico e patogénico que reside de forma 
comensal nas superfícies mucosas humanas. Este fungo apresenta um código 
genético ambíguo, uma vez que, o codão universal leucina CUG é 
predominantemente traduzido como serina (97%), mas também como leucina 
(3%). A análise de proteínas de C. albicans que contêm resíduos CUG em 
importantes posições funcionais, revela que a ambiguidade do codão modela a 
função da proteína e poderá ter um papel determinante nas vias de sinalização 
associadas a mudanças morfológicas e patogénicas. 
Com o presente estudo pretende-se investigar o efeito da leucina e da serina 
nas posições CUG (ambiguidade CUG) na estrutura e função de duas 
proteínas chave nas vias de sinalização de C. albicans, a Ras1 (GTPase) e a 
Cek1 (Cinase). Estas regulam a transcrição dos genes associados com 
mudanças morfológicas, patológicas e, por outro lado, contêm resíduos CUG 
numa posição estritamente conservada e com relevo funcional. 
Neste contexto foi possível clonar com sucesso genes sintéticos para os 
centros ativos da Ras1 e Cek1 (variantes de serina e de leucina para o codão 
CUG) em vetores que apresentam diferentes caudas de solubilidade (MBP, 
NusA, Trx, ZTag2 e Gb1). Foram desenvolvidos protocolos de alta expressão 
bacteriana e de purificação para os domínios ativos Ras1 (ligado à Gb1) e 
Cek1 (ligado à MBP). A análise dos resultados de purificação analítica e de 
“Dynamic Light Scaterring” demonstraram que as proteínas recombinantes se 
apresentam na forma monomérica.  
Ensaios de cristalização estão a ser realizados esperando-se determinar as 
estruturas tridimensionais das proteínas por cristalografia de raio-X. As 
estruturas da Cek1 e Ras1 com leucina e serina nas posições CUG, 
conjuntamente com uma análise meticulosa da sua estabilidade e função in 
vitro, irão fornecer informações importantes sobre o papel estratégico da 
ambiguidade natural do codão. 
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abstract 
 
The polymorphic fungal pathogen Candida albicans has an ambiguous genetic 
code, as the universal leucine CUG codon is predominantly translated as 
serine (97%) but also as leucine (3%). Analysis of the rare C. albicans proteins 
containing CUG-encoded residues in functionally relevant positions reveals that 
codon ambiguity shapes protein function and might have a pivotal role in 
signaling cascades associated with morphological changes and pathogenesis. 
The present study investigates the effect of leucine or serine at CUG positions 
(CUG ambiguity) in the structure and function of two key effectors of signaling 
cascades in C. albicans, Ras1 (GTPase) and Cek1 (protein kinase), which 
regulate the transcription of genes associated with morphological changes and 
pathogenesis. These two proteins contain a CUG residue in a strictly 
conserved and functionally relevant position. 
Synthetic genes coding for the active domains of Ras1 and Cek1 (serine and 
leucine variants for the CUG codon) were successfully cloned into expression 
vectors carrying different solubility partners (MBP, NusA, Trx, ZTag2 and Gb1). 
Furthermore, using an incomplete factorial approach, high level bacterial 
expression and purification protocols for the active domains of Ras1 (in fusion 
with Gb1) and Cek1 (in fusion with MBP) were developed. Analytical size 
exclusion chromatography (SEC) and dynamic light scattering (DLS) results 
indicate that both recombinant proteins are monomeric. 
Crystallization trials must be done aiming for the determination of their three-
dimensional structures by X-ray crystallography. The structures of Ras1 and 
Cek1 with serine or leucine at CUG positions, together with a thorough analysis 
of their stability and function in vitro, will provide valuable insights into a 
possible strategic role of natural codon ambiguity. 
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A Adenine 
APS Ammonium PerSulfate 
C Citosine 
C. Albicans Candida albicans 
Cek1_Leu Cek1 Leucine variant for CUG codon 
Cek1_Ser Cek1 Serine variant for CUG codon 
CV Column Volumes 
D Diffusion coefficient 
DLS Dynamic Light Scattering 
DNA Deoxyribonucleic Acid 
EDTA Ethylenediamine Tetraacetic Acid 
EIF4E Translation initiation factor 4E 
EtBr Ethidium Bromide 
G Guanine 
GTP Guanosine triphosphate 
HIV Human immunodeficiency virus 
IF Incomplete factorial 
IMAC Immobilized affinity chromatography 
IPTG Isopropyl-β-D-thigalactoside 
LB Luria - Bertani Medium 
Leu Leucine 
LeuRS Leucyl-tRNA synthase 
MAPK Mitogen Active Protein Kinase 
MI Morphological Index 
mRNA messenger Ribonucleic Acid 
PCR Polymerase Chain Reaction 
PEG Polyethyleneglycol 
Pi Inorganic phosphate 
PI Polydispersity Index 
PMSF Phenylmethylsulfonyl fluoride 
Ras1_Leu Ras1 Leucine variant for CUG codon 
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Ras1_Ser Ras1 Serine variant for CUG codon 
RH Hydrodynamic radius 
RNA Ribonucleic Acid 
S. cerevisiae Saccharomyces cerevisiae 
SAP Shrimp Alkaline Phosphatase 
SDM Site Directed Mutagenesis 
SDS Sodium Dodecyl Sulfate 
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
SEC Size-exclusion chromatography 
Ser Serine 
SerRS Seryl-tRNA synthase 
TAE Tris-Acetate-EDTA 
TEMED Tetramethylethylenediamine 
tRNACAG
Leu Leucine-tRNA 
tRNACAG
Ser Serine-tRNA 
U Uracile 
V0 Void volume of the column 
Ve Elution volume 
Vt Total bed volume 
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1.1. Candida albicans: a human pathogen 
The Yeast Candida albicans (C. albicans) is the most common fungus present in the human skin 
and mucosal (1), and, although commensal, it also causes superficial infections and life-
threatening systemic disease (2). With the increase of immunocompromised individuals due to 
HIV infection, organ transplantation, and application of chemotherapy, invasive candidiasis has 
become a serious public health problem in the recent decades (2). This extremely serious medical 
condition has a mortality rate of about 40% (1,3), and about 90% of the invasive infections are 
caused by five species of Candida: albicans, glabrata, parapsilosis, tropicalis and krusei (3).  
The pathogenic nature of C. albicans is attributed to: its multiple surface structures that mediate 
adhesion to epithelial cells; the capacity to switch its phenotype by regulating gene expression; 
the ability to introduce hydrolytic enzymes that damage host cells; the capacity to produce 
biofilms resistant to the antifungal drugs; metabolic and stress adaptation during infection and 
the capacity to switch between yeast, hyphae and pseudohyphal forms (1). When growth begins, 
elongated cells are produced and pseudohyphal/hyphal can be distinguished by their general sizes 
and shapes, and according to their morphological index (MI). The MI measures the relative 
lengths and septal diameters of the cells (3,4). Other morphological differences that can be 
mentioned are that hyphal cells are thinner than pseudohyphal cells and have parallel walls 
without constrictions at the septum site, whereas pseudohyphal cells are bigger and form 
constrictions between elongated sprout (5) (Figure 1). 
 
 
Figure 1- Distinct morphological forms of Candida albicans between yeast (a), pseudohyphal (b) 
and hyphal (c). Figure adapted from Shapiro et al., 2011. 
 
At the base of this morphological types are differences at the molecular level, namely in cell cycle 
regulation (for review Shapiro et al., 2011). As stated to above, changes in C. albicans 
morphological state are important for the virulence of this fungus. Even though some studies 
a b c 
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indicate that both yeast and filamentous states are related with virulence (3,6), filamentous forms 
are generally accepted as being responsible for tissue invasion and a more deep infection, 
whereas yeasts are regarded as important for the first state of dissemination and the subsequent 
infection processes (7). To induce disease, yeast cells adhere to both oral and intestinal epithelia, 
quickly change its forms to hyphal growth (1) and invade endothelial cells leading to tissue 
damage. However, the fungus is normally benign and it is well tolerated by the immune system. 
This morphological switching is regulated by the environmental conditions that the fungus 
encounters in the medium of invasion and is influenced by the microbiological flora present in the 
host (1). The host specific immune response to the invasion is mediated by macrophages (8). 
 
1.2. The CUG ambiguity in C. albicans 
The discovery of the genetic code lead Crick to postulate different rules for the transmission of 
genetic information, one of them was that the genetic code was frozen during time (9). For this 
reason the first discoveries about how the genetic code was changing were not well accepted by 
the scientific community that described them as nature aberrations (10). However, later studies 
lead to discover that not all changes had a negative impact in nature and that the manipulation of 
the genetic code rules could have a positive impact (11–16). Many microorganisms such as 
phages, bacteria or yeast are known to suffer modifications in their phenotypes as a consequence 
of induced-genetic code ambiguity resulting in a high adaptation potential (14). 
In this context, a unique genetic code was described in several species of Candida and 
Debaryomyces genera (CTG clade) in which the leucine CUG codon is ambiguously decoded as 
serine (ser) and leucine (leu), being this sense-to-sense reassignment a characteristic of this two 
genera, in which canonical leucine-identity of nuclear CUG codons was replaced to serine. This 
ambiguity has been proven to be a consequence of a mutant serine-tRNA (tRNACAG
Ser) which has 
an anticodon (5’-CAG-3’) that matches with the CUG codon from mRNA sequence (17,18). This 
tRNACAG
Ser gene has evolved from tRNACGA
Ser gene through insertion of an adenosine (A) in the 
middle position of CGA anticodon which created the CAG anticodon sequence coupled to the 
mutant tRNACAG
Ser as represented in Figure 2 (12,19). 
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Figure 2- Scheme of the adenosine insertion in the anticodon of tRNACGA
Ser leading to a mutant 
tRNACAG
Ser. 
 
Consequently, in the yeast ancestral CUG codons were ambiguously decoded as serine by mutant 
tRNACAG
Ser and as leucine by tRNACAG
Leu, a tRNA which was later lost during Candida spp evolution 
(12). This created a unique contradiction to the genetic code rules since the same codon was 
translated into two different amino acids. 
The CUG identity alteration from leucine to serine was initiated 272±25 million years ago evolving 
gradually, until our days that CUG codon is ambiguously decoded as serine and as leucine (12). 
This is explained by the fact that the novel tRNACAG
Ser has suffered mutations during evolution that 
affected the recognition and leucylation by the Leucyl-tRNA synthase (LeuRS). Accordingly, the 
tRNACAG
Ser is recognized by the Seryl-tRNA synthase (SerRS) and LeuRS giving rise to two distinct 
tRNA species, namely Ser-tRNACAG
Ser and Leu-tRNACAG
Ser. These tRNAs participate in protein 
synthesis making CUG ambiguously decoded (16) (Figure 3). However, SerRS is the main charging 
enzyme of tRNACAG
Ser and the LeuRS is a poor competitor (16) (Figure 3). 
Legend: 
A- Adenosine; 
G- Guanine; 
C- Cytosine; 
U- Uracil. 
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Figure 3- Schematic representation of the competition between the SerRS and the LeuRS for 
charging the tRNACAG. 
 
In vitro serine and leucine are incorporated into the proteome with different levels of efficiency: 
97% of tRNACAG
Ser is charged with serine and only 3% is charged with leucine (20). It has been 
previously demonstrated that leucine misincorporation can be increased up to 28% in C. albicans 
without visible effects on the growth rate but with an impressive impact in cell morphology (16). 
In agreement with these findings, the analysis of CUG-containing genes in C. albicans showed that 
in most of the genes the CUG encoded residues is neutral and in general it does not affect the 
protein folding and consequently its function (21). 
Although seemingly tolerated, those surface Leu-for-Ser replacements will hardly occur without 
subtle structural and functional consequences. In agreement, functional differences were recently 
reported in C. albicans eukaryotic translation initiation factor 4E (EIF4E) upon incorporation of 
serine or leucine within a non-conserved site at the protein surface (22). Moreover, considering 
that surface residues are often mediating macromolecular interactions it can be expected that 
CUG ambiguity in C. albicans will have an impact on protein activity and regulation. In the SerRS of 
C. albicans, the amino acids codified by CUG codon are located at the protein surface and 
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although it does not affect the overall structure, it has functional consequences and the isoform 
with CUG-encoded leucine is more active (23). 
It was previously shown that the partial reversion of CUG decoding from serine to leucine in C. 
albicans up-regulated the expression of genes involved in cell adhesion and hyphal growth as well 
as increased the secretion of proteases and phospholipases (13,16) features associated with 
virulence and infection (24). In addition, a small number of proteins associated with 
morphogenesis and virulence in Candida species, were recently identified, particularly proteins 
involved in Mitogen Active Protein Kinase (MAPK) Pathway (23) as Ras1 and Cek1. These two C 
albicans proteins are crucial in signal transduction pathways associated with morphological 
switching and virulence, and moreover contain CUG encoded residues in strictly conserved sites 
where the replacement of Ser-to-Leu should have a bigger functional impact. Supporting this idea, 
increased leucine misincorporation up-regulated the expression of an adhesin (13), which is 
positively controlled by Ras1-dependent signalling cascades (25-26). 
 
 
Figure 4- Key cellular signaling cascade regulating the morphogenesis and the vegetative growth 
in Candida albicans. Numerous signaling pathways regulate C. albicans morphogenesis being one 
of them the Mitogen Active Protein Kinase (MAPK) Pathway. Schematic representation taken 
from the article Shapiro et al., 2011. 
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1.3. Ras1 and Cek1 proteins from C. albicans 
Ras1 is a guanine nucleotide binding protein (GTPase) which acts downstream of Mep2, a 
transmembrane ammonium permease that regulates yeast-to-hypha morphogenesis in response 
to nitrogen starvation. The small GTPase, is as a sensor of environmental stress signals which 
activates two signalling cascades the (cAMP)-dependent protein kinase pathway and the MAP 
kinase-dependent pathway. The activation of cAMP and MAPK pathways culminates in 
morphological changes and disruption of genes encoding proteins, resulting in reduced virulence 
(25–27). Another member of the MAPK signal pathway is Cek1, an ERK-family protein kinase. Cek1 
is mainly involved in: wild-type yeast-hyphal switching, mating efficiency and virulence (28). The 
Cst20p-Hst7p-Cek1p-Cph1p MAPK pathway (Figure 4) is the regulator of mating, and invasive 
hyphal growth under nutrition starvation (28–30). 
Cek1 and Ras1 were identified in C. albicans as being crucial to the signal transduction mechanism 
of morphological switching and virulence (25,28,31) and contain CUG-encoded residues. The 
three-dimensional models of Ras1 and Cek1 have been analyzed in detail using homology models 
(23). Ras1 GTPase has CUG encoded residue in a conserved Ser/Thr position and Cek1 protein 
kinase has a CUG-encoded residue in a strictly conserved Ser position (23) (Figure 5 and Figure 6). 
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Figure 5- Amino acid sequence alignment of Cek1 from different Candida species (C. albicans, C. 
tropicalis, C. parapsilosis, C. guilliermondii, C. lusitaniae, C. glabrata) and S. cerevisiae. The CUG 
encoded residues are boxed in green except for C. albicans, which is boxed in blue. Strictly 
identical residues are shown in red background and conserved residues are shown in red type. 
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Figure 6- Amino acid sequence alignment of Ras1 from different Candida species (C. albicans, C. 
tropicalis, C. parapsilosis, C. guilliermondii, C. lusitaniae, C. glabrata) and S. cerevisiae. The CUG 
encoded residues are boxed in green except for C. albicans, which is boxed in blue. Strictly 
identical residues are shown in red background and conserved residues are shown in red type. 
 
In C. albicans Ras1 GTPase, the CUG-encoded Ser66 is part of the conserved active site whose 
flexibility is crucial for cycling between active and inactive states and for binding Ras1 effectors 
and regulators (32,33) (Figure 7). Mutations in this region, locking Ras1 in the active GTP-bound 
conformation, have been indentified in human tumors (33) and shown to generate transient 
activated phenotypes in S. cerevisiae (34). Likewise, in the C. albicans Cek1 protein kinase model 
(23), the conserved CUG-encoded Ser199 is facing the ATP-binding-pocket, and hence leucine 
incorporation at this site will likely interfere with its catalytic activity (Figure 7). C. albicans Ras1 
and Cek1 proteins are plausible early molecular effectors of morphological switching upon 
 C. albicans Cek1 and Ras1: cloning, expression and purification 
 
 
 
15 
 
increased leucine misincorporation (e.g., upon pH or oxidative stress) (16). In this work we 
purpose to develop protocols for the expression and purification of Cek1 and Ras1 active domains 
in high yields, with the purpose of determining the structural and functional consequences of 
serine to leucine exchange (CUG-encoded residue) in Ras1 and Cek1 of C. albicans. 
 
 
Figure 7- Functional impact of serine/leucine incorporation in C. albicans Ras1 and Cek1 proteins. 
(A) Homology model of C. albicans Ras1 GTPase based on the human Ras structure 3K8Y (35). The 
CUG-encoded Ser66 has carbon atoms represented in magenta and the active site bound GNP (no 
hydrolyzable GTP) is shown in orange. In human Ras, the incorporation of leucine at position 66 
will likely interfere with GTP hydrolysis. (B) Homology model of C. albicans Cek1 protein kinase 
based on the yeast Fus3p structure 2B9F (36). The CUG-encoded Ser 199 (in magenta) is inside 
ATP-binding pocket (carbon atoms of bound ADP molecule in blue). Introduction of a leucine at 
this position is expected to compromise the Cek1 active site. Residues represented as sticks are 
color-coded (nitrogen in blue, oxygen in red phosphate in orange, carbon in gray unless stated 
otherwise), hydrogen bonds are represented by dashed black lines. Figure and legend adapted 
from article R. Rocha, Pereira, et al., 2011. 
 
2. Objectives 
So far is known that Ras1 (GTPase) and Cek1 (protein kinase), which are crucial in the signal 
transduction mechanism of morphological switching and virulence in C. albicans, contain only one 
CUG residue in a strictly conserved and functionally relevant position. Hence the CUG ambiguity 
might regulate the function of Ras1 and Cek1. To confirm this possible strategic role of CUG 
ambiguous decoding in Ras1 and Cek1, comparative structural and functional in vitro studies are 
essential. These studies require high amount of pure soluble proteins. 
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The main goals of the present work were to clone, express and purify the active domains of Ras1 
and Cek1, containing either serine or leucine at the CUG encoded position. We aimed to design 
and develop bacterial expression and purification protocols, in order to get high amount of pure 
soluble recombinant proteins. This is crucial for further structural and functional studies in order 
to determine consequences of serine or leucine incorporation within the CUG-encoded residue in 
C. albicans Ras1 and Cek1. 
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3.1. Cloning  
Synthetic genes of Ras1_Ser (serine variant for CUG codon) and Cek1_Leu (leucine variant for 
CUG codon position) were purchased (Eurofins MWG Operon) with the codon optimized for 
Escherichia coli in a standard vector with restriction sites NcoI and Acc65I for 5’ and 3’ end 
respectively (see section 6, Figure 36 and Figure 37). 
 
3.1.1. Polymerase Chain Reaction 
The gene fragments for the active domains of Ras1_Ser and Cek1_Leu were amplified from the 
standard vectors by Polymerase Chain Reaction (PCR). Two primers were designed for each 
PCR reaction. The forward primer (extends in PCR from the start codon towards the stop 
codon) contained an NcoI restriction site; and the reverse primer (extends from the stop codon 
towards the start codon) included an Acc65I restriction site (see Table 1). Using these primers 
in the PCR reactions, the gene fragments (for the active domains of Cek1 and Ras1) were 
amplified with the restriction sites NcoI and Acc65I for 5’ and 3’ end respectively.  
 
Table 1 – Primer sequences to amplify gene fragments for the active domains of Ras1_Ser and 
Cek1_Leu. Restriction site for NcoI and Acc65I are presented in blue and green respectively. 
Primer Sequence (5´→3´) GC (%) Length (nt) 
Cek1_for CCGGCCATGGGCAGTCCACGTCAGGTCAGC 70 30 
Cek1_rev CCGGGGTACCTTATTTCATGATTTCTTCATACAG 41.1 34 
Ras1_for CCGGCCATGGCGCTGCGTGAATACAAAC 60.7 28 
Ras1_rev CCGGGGTACCTTAGTTGATGTTGCGCACCAG 58 31 
 
The amplification reactions were performed with Phusion High-Fidelity DNA Polymerase 
(Thermo Scientific) in a temperature cycler MyCyclerTM Thermal Cycler (Bio-Rad). The cycling 
conditions are shown in Table 2 -Table 3.   
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Table 2- PCR conditions for the amplification of gene fragment for the active domain of 
Cek1_Leu. 
Reaction mixture Cycling conditions 
Reagent 
Final 
Concentration 
Temperature (°C) Time (min) Number cycles 
10 ng DNA template 
(pBluescript/CEK1) 
0.2 ng ul-1 98 °C 2 min 1 
5x Phusion HF Buffer 
(Thermo Scientific) 
1 x 98 °C 10 sec 
30 
10 µmol Primer 
forward (Sigma) 
0.3 µmol 72 °C 50 sec 
10 µmol Primer 
reverse (Sigma) 
0.3 µmol 72 °C 10 min 
40 mM/each dNTPs 
(Bioron) 
0.8 mM 4°C ∞  
5 Uµl-1 Phusion High-
Fidelity DNA 
Polymerase (Thermo 
Scientific) 
0.05 U µl-1  
 
Table 3– PCR conditions for the amplification of gene fragment for the active domain of 
Ras1_Ser. 
Reaction mixture Cycling conditions 
Reagent 
Final 
Concentration 
Temperature (°C) Time (min) Number cycles 
10 ng DNA template 
(Pcr2.1/RAS1) 
0.2 ng ul-1 98 °C 2 min 1 
5x Phusion HF Buffer 
(Thermo Scientific) 
1 x 98 °C 10 sec 
30 
10 µmol Primer 
forward (Sigma) 
0.3 µmol 72 °C 45 sec 
10 µmol Primer 
reverse (Sigma) 
0.3 µmol 72 °C 10 min 
40 mM/each dNTPs 
(Bioron) 
0.8 mM 4°C ∞  
5 Uµl-1 Phusion High-
Fidelity DNA 
Polymerase (Thermo 
Scientific) 
0.05 U µl-1  
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3.1.2. DNA electrophoresis, agarose gel 
After performing the PCR reactions a small aliquot (1μl) from reaction mixtures was analyzed 
on a 1%(w/v) agarose gel. For routine work , 1%(w/v) agarose gels were prepared by dissolving 
the agarose in TAE buffer (40 mM Tris, 20 mM acetic acid, 1mM EDTA) followed by boiling in a 
microwave oven until completely melted. Thereafter, the agarose solution was cooled to 
approximately 60 °C and 2% (v/v) of Ethidium Bromide (EtBr, AppliChem) was added followed 
by pouring onto a gel tray. Before loading, the DNA samples were mixed with 6X Loading Dye 
buffer (Fermentas) allowing the visual tracking of DNA migration during electrophoresis. The 
DNA electrophoresis was performed at 100 volts for 1 hour in a submerged horizontal 
electrophoresis system (Mini-sub cell GT, Bio-Rad). The electrophosed DNA was analyzed by 
exposing the gel to the UV light (Gel Doc instrument, Quantity One software, Bio-Rad). 
  
3.1.3. DNA purification from PCR reaction 
After confirming the good quality of PCR reaction, the DNA fragments/inserts (for the active 
domains of Cek1_Leu and Ras1_Ser) were purified from PCR mixture by QIAquick® PCR 
Purification Kit (Qiagen) according to the manufacturer instructions. The purified DNA was 
quantified by measuring the absorbance at 260 nm (A260) (NanoDrop ND-1000 
Spectrophotometer Thermo Scientific). The A260/A280 ratio was used to estimate DNA purity 
which is expected between 1.8 and 2.0 (37). 
 
3.1.4. Double digestion of inserts 
The purified PCR products (gene fragments for active domain of Cek1_Leu and Ras1_Ser) were 
digested with NcoI and Acc65I restriction enzymes (Fermentas). The double digestions with 
these two restriction enzymes were performed in 2X Tango buffer using two fold excess of 
Acc65I. Digestion time of both PCR products (inserts) was 2 hours at 37 °C. After the double 
digestion, the two restriction enzymes (NcoI and Acc65I) were inactivated at 65 °C for 10 min. 
Thereafter the double digested inserts were purified by QIAquick® PCR Purification Kit (Qiagen) 
and DNA was quantified as described in 3.1.3 section.  
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3.1.5. Expression vectors 
Five different pET derived (pETGB, pETZ2, pETNusA, pETMBP and pETTrx) expression vectors 
were used to clone the gene fragments for the active domain of Cek1_Leu and Ras1_Ser. The 
main difference between these five pET vectors it is in their solubility tags (see Figure 8). In all 
five pET constructions the insert will be separated by a TEV cleavage site from an N-terminal 
His6tag and solubility tag (depending on the vector).  
 
 
Figure 8 – Schematic representation of five pET vectors with their different solubility tags.  
 
All five vectors were double digested with NcoI and Acc65I under the same conditions 
described in section 3.1.4 except, the digestion took longer (4 h), due to the bigger size of 
circular vectors. After digestion the restriction enzymes were inactivated (60 °C, 20 min) and 
the sample was treated with Shrimp Alkaline Phosphatase (SAP) to avoid recircularization of 
the cloning vectors. As a consequence of the double digestion the DNA sequence for GFP was 
cleaved from the pET expression vectors. Thereafter the linearised double digested expression 
vectors were isolated with agarose gel electrophoresis (DNA fragment was excised under the 
UV light) and purified using the QIAquick® Gel Extraction Kit (Qiagen). The purified DNA was 
quantified as described in 3.1.3 section. 
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3.1.6. Ligation into expression vectors 
The two pure double digested inserts (active domains of Cek1_Leu and Ras1_Ser, hereinafter 
referred as Cek1_Leu and Ras1_Ser) were ligated in the all five pure, double digested 
expression vectors (see section 3.1.4). Ligations were performed with 1 u T4 DNA ligase 
(Fermentas) using a molar ratio of 1:4 vector to insert in a total reaction volume of 10 µl, 
overnight at 20 °C, in 1x T4 DNA ligase buffer (50 mM Tris-HCl, pH 7.5; 10 mM MgCl2, 1 mM 
ATP, 10 mM Dithiothreitol, Fermentas). In order to convert molar ratios to mass ratios the 
equation (1) was used:  
 
ng of insert 
ng vector     si e insert
   si e of vector
   
molar ra o of insert
vector
                                             1  
 
3.1.7. Isolation and purification of plasmid DNA 
After performing the ligation reaction, 50 μl of E. coli DH5α competent cells were transformed 
with 5μl of ligation mixture as descri ed in section 3.1.9. The positive transformants were 
selected by plating onto Luria-Bertani (LB) agar plates, [1% (w/v) tryptone, 1% (w/v) NaCl, 0.5% 
(w/v) yeast extract, 1.5% (w/v) agar] supplemented with 50 μg/ml kanamycin (Kan; Sigma) and 
grown overnight at 37 °C. In order to check if the expression vector contained the insert 
(Cek1_Leu or Ras1_Ser) five colonies were grown overnight at 37 °C in liquid LB medium with 
selective antibiotic (Vculture = 10 ml) and the plasmid DNA was purified with NZYMiniprep Kit 
(NZYTech) according to the manufacturer´s instructions, doubling the volumes of buffers A1, 
A2 and A3. The purified plasmid DNA was quantified (see section 3.1.3) and tested for the 
insert by double digestion with NcoI and Acc65I restriction enzyme. Alternatively the positive 
transformants, after ligation, were tested for the insert by performing a colony PCR. In this 
method 5μl overnight cultures (of each five colonies, as descri ed a ove) were used as DNA 
templates in PCRs. In these PCRs the inserts were amplified with same primers and in the same 
conditions as were used to amplify gene fragments for the active domains of Ras1_Ser and 
Cek1_Leu (see section 3.1.1,Table 2 and Table 3). The purified plasmid DNA samples were sent 
to Eurofins MWG Operon (Germany) for sequencing. 
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3.1.8.  Site directed mutagenesis (SDM) 
The Ras1_Leu (leucine variant for CUG codon) and Cek1_Ser (serine variant for CUG codon) 
were prepared by QuikChange site directed mutagenesis. This method allows site-specific 
mutation in any double-stranded plasmids. The pET expression plasmids cloned with Ras1_Ser 
or Cek1_Leu (section 3.1.6) were used as template in the mutagenesis reaction. For both SDM 
(Cek1 and Ras1) two primers were designed using software provided by Stragene Genomics 
(https://www.genomics.agilent.com/homepage.aspx). These primers are two complementary 
DNA oligonucleotides that contain the desired mutation, flanked by unmodified nucleotide 
sequence (Table 4). With Ras1_Leu mutagenic primers, the CUG codon was mutated to 
leucine-UUG in order to create the Leu67 variant of Ras1_Leu. Furthermore, with Cek1_Ser 
mutagenic primers the CUG codon was mutated to serine UCG to obtain the Ser146 variant of 
Cek1_Ser. The SDM reactions were performed with Pfu Turbo DNA polymerase (Stratagene) 
for high fidelity and robust amplification of long DNA templates with a temperature cycler 
(MyCyclerTM Thermal Cycler, Bio-Rad), using the cycling PCR conditions described in Table 5. 
The product was then treated with 10 Units of Dpn I endonuclease (Fermentas) for 1h at 37 °C. 
Dpn I is specific for methylated and hemimethylated DNA (target sequence 5’-Gm6ATC-3’) and 
used to digest the parental DNA template and to select for mutation-containing newly 
synthesized DNA. DNA isolated from almost all E. coli strains is dam methylated and therefore 
suscepti le to Dpn I digestion. After selection of mutated DNA plasmid, 10 μl of the SDM 
reaction were used to transform 50 μl of E. coli DH5α competent cells as descri ed in section 
3.1.9. The positive transformants were selected by plating onto LB-agar plates supplemented 
with 50 μg/ml Kan and growing overnight at 37 °C. DNA plasmid isolation and purification was 
performed on two isolated colonies as described in section 3.1.7. The pure DNA plasmid 
samples were sent for sequencing. 
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Table 4- Primers used to create Ras1_Leu and Cek1_Ser.  
Primer Sequence (5´→3´) Tm (⁰ C) Length (nt) 
Ras1_67Leu_for ACAGCTGGTCAAGAAGAGTATTTGGCAATGCGCGA 79.27 35 
Ras1_67Leu_rev TCGCGCATTGCCAAATACTCTTCTTGACCAGCTGT 79.27 35 
Cek1_146Ser_for CTGAAGCCCTCCAACTTGTCGCTGAACTCCAATT 78 34 
Cek1_146Ser_rev AATTGGAGTTCAGCGACAAGTTGGAGGGCTTCAG 78 34 
 
Table 5- Reaction mixture (left) and cycling conditions (right) for SDM of Ras1 and Cek1 active 
gene fragment. 
Reaction mixture Cycling conditions 
Reagent Final 
Concentration 
Temperature (°C) Time (min) Number cycles 
5 ng µl-1 DNA 
plasmid 
0.1 ng µl-1 95 °C 30 sec 1 
10x Reaction 
Buffer (Stragene) 
1x 95 °C 30 sec 
16 
125 ng µl-1 primer 
forward (MWG) 
2.5 ng µl-1 55 °C 1 min 
125 ng µl-1 primer 
reverse (Sigma) 
2.5 ng µl-1 68 °C 10 min* 
10 mM/each 
dNTPs (Sigma) 
1.28 mM 68 °C 10 min  
2.5 Uµl-1 Pfu Turbo 
DNA polymerase 
(Stratagene) 
0.05 U µl-1 4°C ∞  
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3.1.9. Preparation of competent cells and E. coli transformation 
In order to induce reproducible and highly efficient transformation of bacterial cells with 
expression vector, competent cells were prepared. For this purpose, a fresh single colony was 
inoculated into 50 ml of LB medium (with antibiotic selection, if necessary) which grew 
overnight at 37 °C with vigorous shaking [180 rpm, in a IKA KS 4000 I-Control (IKA®) 
incubator shaker]. In the following day a 2 ml aliquot was used to inoculate 200 ml of LB 
medium (pre-mixed with MgCl2 to a final concentration of 20 mM) and the cells grew until the 
optical density at 600 nm (A600) reached the value of 0.4 – 0.5. The cell growth was stopped by 
incubating the culture on ice for 15 min, the cells were pelleted by gentle centrifugation at 
3000 rpm (Hettich Universal 320R) for 5 min at 4 °C, and the pellet was carefully resuspended 
in 25 ml of ice-cold CaCl2 (100 mM) and then incubated on ice for 20 min. The cells were gently 
centrifuged again, then resuspended in 2ml of ice-cold CaCl2 (100 mM) and 600 μl glycerol 
(100%). This resuspension was distributed into eppendorfs pre-chilled in ice-bath and 
immediately flash-frozen in liquid nitrogen. Competent cells were stored at -80 °C. Table 6 
contains the E.coli strains (competent cells) used for optimization of Cek1 and Ras1 expression. 
 
Table 6- E. coli strains used for optimization of Cek1 and Ras1 expression. 
Strain Description/Application 
Antibiotic 
resistance 
Supplier 
BL21StarTM(DE3) 
Lacks a functional RNAase enzyme 
resulting in higher mRNAs stability. 
-------------------- Stratagene 
BL21(DE3)pLysS 
Carries a T7 RNA polymerase inhibitor 
to suppress the basal recombinant 
protein expression, prior to induction. 
Chloramphenicol 
34 µg ml-1 
Stratagene 
Rosetta(DE3) 
A BL21(DE3) derivative but provides six 
extra tRNAs decoding the rare codon 
AGG, AGA, AUA, CUA,CCC and GGA. 
Chloramphenicol 
34 µg ml-1 
Novagen 
Origami2(DE3) 
Have mutations in both the thioredoxin 
reductase and glutathione reductase 
genes, which greatly enhances disulfide 
bond formation in the cytoplasm. 
Kanamycin 
50 µg ml-1 
Stratagene 
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Competent bacterial cells were transformed using the standard heat-shock method. 50µl of 
these cells were incubated with 10-100 ng of pET expression vectors (see section 3.1.5) on ice 
during 30 min. The heat shock was performed at 42 °C for 45 sec, followed by incubation on 
ice for 2 min. Thereafter 600 µl of LB medium were added to each transformation reaction and 
the cells were allowed to recover at 37 °C for 60 min with shaking (170 rpm). Cells were 
pelleted by centrifugation (600 g for 1 min) at room temperature and 500 µl of the 
supernatant were discarded. The cells were resuspended in the remaining LB medium and 
plated on LB-agar plate containing the selected antibiotic. The plates were incubated at 37 °C 
overnight. (grown overnight at 37 °C until 15 hours). A negative control was performed in 
parallel, without plasmid DNA addition. 
 
3.2. Protein expression and purification 
3.2.1. Trx_Cek1_Leu expression tests 
Expression of soluble Cek1_Leu in fusion with Trx tag (pETTrx/Trx_Cek1_Leu construct) was 
first assessed at analytical scale (50 mL cultures) using an incomplete factorial (IF) approach 
(38) combining three E. coli strains (BL21Star(DE3), Origami2(DE3) and Rosetta(DE3), three 
temperatures (20, 25 and 30 °C) and two medium (LB and 2YT). Using SAmBA software 
(http://igs-server.cnrs-mrs.fr/samba/) 9 IF combinations (see Table 7) can be obtained out of 
the 18 combinations of the corresponding full factorial (3 E. coli strains x 3 exp. temperature x 
2 medium). In all 9 experiment (see Table 7) the protein expression was induced by adding 
Isopropyl-β-D-thigalactoside (IPTG) to a final concentration of 0.9 mM and incubating for 3-4 
hours or overnight depending on temperature, 25/30 °C and 20 °C respectively. After protein 
expression the cultures were (9 x 50 ml) harvested at 5000 rpm, 4 °C for 10 min (Hettich 
Universal 320R centrifuge). The supernatant was discarded and the pellets were resuspended 
in 2 ml lysis buffer (40 mM Tris-HCl, 200 mM NaCl, 5 mM 2-mercaptoethanol, pH7.5). Cells 
were lysed by sonication in a Sonoplus HD2200 200 W sonicator (Bandelin Electronic) for 3 x 3 
seconds 10 % duty cycle and 10 % output conditions. Then lysates (9 x 2ml) were centrifuged 
at 13000 rpm (Eppendorf 5414), for 15 min at 4 °C. The supernatants, the soluble fractions, 
were removed in new tubes and the pellets, the insoluble fractions were resuspended in 2 ml 
(9 x 2ml) lysis buffer. Then both soluble and insoluble fractions were analyzed by Sodium 
Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE). The condition yielding the 
higher levels of soluble recombinant protein was selected for experimental scale-up. 
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Table 7- IF approach conditions used to test Trx_Cek1_Leu expression. 
Combination Competent cell 
Exp. Temp 
(°C) 
Medium 
1 Origami2(DE3) 25 LB 
2 BL21StarTM(DE3) 25 2YT 
3 Origami2(DE3) 30 2YT 
4 Rosetta(DE3) 30 2YT 
5 BL21StarTM(DE3) 20 2YT 
6 Origami2(DE3) 20 2YT 
7 Rosetta(DE3) 20 LB 
8 Rosetta(DE3) 25 LB 
9 BL21StarTM(DE3) 30 LB 
 
3.2.2. High-scale expression of Trx_Cek1_Leu 
Trx_Cek1_Leu was overexpressed in Escherichia coli strain Rosetta(DE3) (see Table 6). 
Competent cells previously transformed with pETTrx/Cek1_Leu plasmid were plated onto LB-
agar plates containing 50 μg/ml kanamycin and 34 μg/ml chloramphenicol and incubated 
overnight at 37 °C. A colony was picked and transferred to 50 ml of LB medium containing 50 
μg/ml kanamycin and 34 μg/ml chloramphenicol and incubated overnight at 37 °C. In the 
following day, 700 µl aliquots were used to inoculate 4 X 500 ml portions of LB medium (in 
2000 ml Erlenmeyer flasks) containing 50 μg/ml kanamycin and 34 μg/ml chloramphenicol and 
cells were grown at 37 °C until A600 reached 0.7- 0.9. Then, temperature was decreased to 20 
°C and Trx_Cek1_Leu expression was induced by adding IPTG to a final concentration of 0.9 
mM. Incubation continued at 20 °C for 18 hours (overnight). Cells were harvested by 
centrifugation for 25 minutes at 4000 rpm (Beckman JLA-8.1000 rotor, Avanti J-26 XPI). The 
bacterial pellets were resuspended in 30 ml lysis buffer [40 mM Tris-HCl, 500 mM NaCl, 5 % 
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glycerol (v/v) 5 mM 2-mercaptoethanol, pH7.5] supplemented with 100 μg/ml lysozyme 
(Sigma) and stored at -20 °C. 
3.2.3. Purification of Trx_Cek1_Leu 
Immobilized metal affinity chromatography 
Ressuspended bacterial pellets were thawed and phenylmethylsulfonyl fluoride (PMSF) was 
added to a final concentration of 1 mM. Cells were lysed by sonication in a Sonoplus HD2200 
200 W sonicator (Bandelin Electronic) for 3 min with a 50 % duty cycle. Lysates were 
centrifuged for 45 minutes at 15000 rpm , using a Beckman JA-25.50 rotor. The supernatant 
was filtered through a 0.2 μm filter and then applied to a 5 ml HisTrap HP column (GE 
Healthcare) previously equilibrated with binding buffer (20 mM imidazole , 500 mM NaCl, 5% 
glycerol, 5 mM 2-mercaptoethanol, 40 mM Tris-HCl, pH 7.5). The chromatography system 
consisted of an Econo gradient pump with a SV-5 buffer select valve (Bio-Rad), a UV-vis 
detector model 112 (Gilson) and a Kipp & Zonen chart recorder. Alternatively an AKTAprime 
Plus (GE Healthcare) chromatography system was used. Column was washed with 10 column 
volumes of binding buffer. Elution was induced by a step gradient of 5 %, 15%, 40% and 100 % 
elution buffer (500 mM imidazole, 500 mM NaCl, 5% glycerol, 5 mM 2-mercaptoethanol, 40 
mM Tris-HCl pH 7.5). Fractions were analysed by SDS-PAGE (12.5 % gel) to assess purity. 
Thereafter fractions containing His-tagged Trx_Cek1_Leu were combined and concentrated (to 
a maximum volume of 5 ml) by Amicon Ultra 15 centrifugal concentrator with a 10 kDa cut-
off (Millipore Corporation). Subsequently, this sample was further purified by size-
exclusion chromatography. 
 
Preparative size-exclusion chromatography (SEC) 
A Hiprep 26/60 Sephacryl S-100 (GE Healthcare) column was adapted to AKTAprime Plus (GE 
Healthcare) or BioLogic Duo Flow system (Bio-Rad). The sample was filtered through a 0.2 μm 
filter before injection. An isocratic elution in gel filtration buffer [300mM NaCl, 5% (v/v) 
glycerol, 1mM EDTA, 1mM DTT, 40 mM Tris-HCl, pH 7.5] was monitored by optical density at 
280 nm. Collected fractions were analyzed by SDS-PAGE (12.5 % gel) to assess purity. Fractions 
containing the target protein were pooled and concentrated using Amicon Ultra 15 centrifugal 
concentrator with a 10 kDa cut-off (Millipore Corporation) to a final concentration of 10 
mg/ml. During concentration the buffer was changed to protein storage buffer [150mM NaCl, 
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5% (v/v) glycerol, 1mM EDTA, 1mM DTT, 20 mM Tris-HCl, pH 7.5]. Concentration of 
Trx_Cek1_Leu was determined by absorption at 280 nm using a theoretical molar extinction 
coefficient of 56310 M-1cm-1. 
 
3.2.4. Expression test for MBP_Cek1_Leu 
Expression of Cek1_Leu in fusion with MBP tag was tested at analytical scale (50 ml) at two 
different expression temperature (20 °C, and 25 °C)  in Escherichia coli strain BL21StarTM(DE3). 
The expression test experiments and analyzes of the results were performed as described for 
Trx_Cek1_Leu (section 3.2.1). 
 
3.2.5. High-scale expression of MBP_Cek1_Leu 
The overexpression of MBP_Cek1_Leu in Escherichia coli strain BL21StarTM(DE3) was 
performed at 20 °C using the same protocol as described for Trx_Cek1_Leu expression (section 
3.2.2) using just one antibiotic: 50 μg/ml kanamycin.  
 
3.2.6. Purification of MBP_Cek1_Leu 
Purification of MBP_Cek1_Leu was performed using the same protocol as described for 
Trx_Cek1_Leu (section 3.2.3) except that a Hiprep 26/60 Sephacryl S-200 (GE Healthcare) 
column was used for size-exclusion chromatography. The pure MBP_Cek1_Leu was 
concentrated to a final concentration of 14 mg/ml. Concentration of MBP_Cek1_Leu was 
determined by absorption at 280 nm using a theoretical molar extinction coefficient of 110045 
M-1cm-1. 
 
3.2.7. Expression test for Gb1_Ras1_Ser 
Expression of Ras1_Ser in fusion with Gb1 tag was assessed at analytical scale (50 ml) at two 
different expression temperatures (20 °C, and 25 °C) in E. coli strain BL21(DE3)pLysS. The 
expression tests were performed as described in section 3.2.1. 
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3.2.8. High-scale expression of Gb1_Ras1_Ser 
Overexpression of Ras1_Ser in fusion with Gb1 solubility tag (pETGb1) was performed in 
BL21(DE3)pLysS cells at 25 °C for 4h in presence of 0.9 mM IPTG as described in section 3.2.2. 
The lysis buffer of Gb1_Ras_Ser contained 5mM of MgCl2 [40 mM Tris-HCl, 5 mM MgCl2 500 
mM NaCl, 5 % glycerol (v/v) 5 mM 2-mercaptoethanol, pH7.5]. 
 
3.2.9. Purification of Gb1_Ras1_Ser 
Purification of Gb1_Ras1_Ser was performed using the same protocol as described for 
Trx_Cek1_Leu (section 3.2.3) except that all buffers used for purification and storage of Gb1-
Ras1_Ser contained 5 mM MgCl2. Concentration of Gb1_Ras1_Ser  was determined by 
absorption at 280 nm using a theoretical molar extinction coefficient of 24995 M-1cm-1. 
 
3.2.10. SDS-PAGE analysis 
The Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) is the method 
used to separate proteins according to their size. Samples from expression and purification 
were analysed by SDS-PAGE. The SDS-polyacrylamide gels were composed by two layers. The 
stacking gel, with approximately 1 cm, was composed by 40% of acrylamide, 0,625 M Tris-HCl 
pH 6.8, 20% SDS, 10% APS and 0,1% TEMED. The separating gel was composed by 12.5% of 
acrylamide, 1.5 M Tris-HCl pH 8.8, 40% of acrylamide, 20% SDS, 10% APS and 1% TEMED. To 
analyze samples resulting from protein expression or purification, SDS-PAGE Loading Buffer 
Dye (2x) was added; to each sample a final concentration of 200 mM DTT was added; samples 
were boiled for 5 minutes and then were loaded on the stacking gel. The gel was stained with 
BluePageTM protein staining solution (Fermentas) according to manufacturer instructions. Gel 
analysis was performed with a densitometer (GS-800, Bio-Rad) and analyzed with the 
QuantityOne software (Bio-Rad). 
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3.3. TEV protease cleavage assay 
Purified MBP_Cek1_Leu was digested by in-house expressed and purified recombinant TEV 
protease (200 mM NaCl; 10% glycerol; 2 mM EDTA; 10 mM DTT; 25 mM NaH2PO4/Na2HPO4 pH 
8.0) in order to cleave the MBP tag together with histidine tag. The ratio of TEV protease to 
fusion protein (MBP_Cek1_Leu) to achieve complete digestion may vary. Therefore pilot 
experiments were performed with small amount of fusion protein (1.4- 2μg) using several 
enzyme/substrate molar ratio (1:2.5; 1:5; 1:10; 1:20). The cleavage was performed at room 
temperature, 2h; in storage buffer of MBP_Cek1_Leu [150mM NaCl, 5% (v/v) glycerol, 1mM 
EDTA, 1mM DTT, 20 mM Tris-HCl, pH 7.5]. 
 
3.4. Analytical Size-exclusion Chromatography 
Analytical size-exclusion (gel filtration) chromatography was used for the determination of the 
molecular weight (oligomerization state) of proteins (MBP_Cek1_Leu, Gb1_Ras1_Ser). The 
technique is based on the ability of gel filtration media to separate molecules according to size. 
For analytical size-exclusion chromatography a Superpose 12 10/300 column (GE Healthcare) 
was assembled in an ÄKTA purifier 10 system (GE Healthcare) and equilibrated with buffer: 
150mM NaCl, 5% (v/v) glycerol, 5 mM MgCl2, 1mM EDTA, 1mM DTT, 20 mM Tris-HCl, pH 7.5. 
Blue dextran 2000 was used for determination of the void volume and ribonuclease A (MW: 
13.7 kDa), chymotrypsinogen A (25 kDa), ovalbumin (43 kDa), albumin (67 kDa) and aldolase 
(158 kDa) were used for column calibration (150 μg of each standard protein). 140 μg 
MBP_Cek1_Leu and 200 μg Gb1_Ras1_Ser samples were loaded into the column. The 
calibration curve was prepared by measuring the elution volumes of the standard proteins, 
calculating their corresponding Kav values and plotting them versus the logarithm of their 
respective molecular weight. The Kav parameter was determined according to the equation (2): 
    
       
       
                                                                                                                                   (2) 
where Ve represents the elution volume,V0 the void volume of the column, and Vt the total bed 
volume. 
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3.5. Dynamic Light Scattering (DLS) analysis 
This method provides the ability to measure size characteristics of proteins in a liquid medium. 
Molecules in solution undergo constant diffusion, which is a result of thermal fluctuations in 
the medium and is referred to as Brownian motion. When a coherent light beam hits a 
spherical molecule in solution, there is a shift in the wavelength of the incoming light. DLS 
measures time-dependent fluctuations in the scattering intensity arising from particles 
undergoing random Brownian motion. They are measured across very short time intervals to 
produce a correlation curve, from which the particle diffusion coefficient and subsequently the 
particle size can be obtained. For monodisperse samples, consisting of a single particle size 
group the correlation curve can be fit to a single exponential form or Cumulant fit (39). The 
hydrodynamic radius (RH) is then calculated from the diffusion coefficient (D) using the Stokes-
Einstein equation (3), where k is the Boltzmann constant, T is the temperature, η is the 
medium viscosity (39). 
RH 
 T
6 ηD
                                                                                                                                                (3) 
By definition, the radius measured by DLS is the radius of a hypothetical hard sphere that 
diffuses with the same speed as the particle under examination. The obtained hydrodynamic 
radius is an average value, weighted by particle scattering intensity. The size distribution 
obtained by DLS is a plot of the relative intensity of light scattered by particles in various size 
classes and is therefore known as an intensity size distribution. If the plot shows a substantial 
tail, or more than one peak, then Mie theory can make use of the input parameter of sample 
refractive index to convert the intensity distribution to a volume distribution (40). This will 
then give a more realistic view of the importance of the tail or second peak (41). The 
polydispersity is the relative standard deviation of a sample and is used to describe the width 
of the particle size distribution. Polydispersity can be defined in the following terms: 
Polydispersity Index (PdI) = Relative variance, Polydispersity (Pd) = Standard deviation (σ) or % 
Polydispersity (%Pd) = Coefficient of variation = (PdI)1/2 × 100 (also called the relative 
polydispersity). A sample is considered monodisperse if the polydispersity is less than 20%, it is 
medium dispersed if this value is in the range of 20–30%, and it is polydispersed for values 
above 30%. Molecular size measurements were carried out in a Zeta sizer Nano Zs DLS system 
(Malvern Instruments) (42) MBP_CEK1 and Gb1_Ras1 samples with concentrations of 14 and 
20 mg/ml respectively in their storage buffer were centrifuged at 100,000 rpm for 40 min at 4 
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°C in an AirfugeTM air-driven ultracentrifuge (Beckman Coulter). Then in a 45-μl DTS 2112 
cuvette, three independent measurements were obtained at 20 °C for each sample. All data 
were then analyzed using DTS (nano) 6.32 software. 
 
3.6. Crystallization screenings 
Crystallization trials were performed with the purified Gb1_Ras1_Ser protein (20 mg/mL) and 
MBP_Cek1_Leu (14.5 mg/ml) by vapor diffusion techniques. Different crystallization conditions 
were screened using the following crystallization kits: Morpheus HT96 and PACT premierTM 
(Molecular Dimensions), screening variables such as pH, anions, and cations in combination 
with the precipitant (poliethyleneglycol - PEG). Sitting drops were employed and the droplets 
contained 1 μl of precipitant solution plus 1 μl of protein solution. The reservoirs contained 
350 μl of precipitant solution. Trays were incubated at 20 °C. The crystallization trays were 
checked after 30 minutes, 24 hours of incubation and thereafter every two days during one 
week and every week during one month. 
 
  
 C. albicans Cek1 and Ras1: cloning, expression and purification 
 
 
 
35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. Results and discussion 
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4.1. Cloning 
The full synthetic genes for Cek1_Leu and Ras1_Ser (see Figure 9A andFigure 10A) were 
purchased with the codon optimized for E. coli in standard vectors: pBluesscript IISK (+) and 
pCR2.1 respectively (see section 6, Figure 36 and Figure 37. The gene fragments for active 
domains of Cek1_Leu and Ras1_Ser (see Figure 9B andFigure 10B were amplified by PCR 
including the restriction sites NcoI and Acc65I for 5’ and 3’ end respectively. Figure 11 shows 
the results of these amplifications: gene fragments for active domain of Cek1_Leu and 
Ras1_Ser.  
 
Figure 9- Candida albicans Cek1_Leu cDNA: (A) full and (B) amplified fragment for active 
domain. The CUG encoded residue (Leu variant in the synthetic gene) is highlighted in green at 
positions: 199 in the full and 146 in the amplified active domain fragment. The first and last 
residues of the active domain fragment are highlighted in yellow. 
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Figure 10- Candida albicans Ras1_Ser cDNA: (A) full and (B) amplified fragment for active 
domain. The CUG encoded residue (Ser variant in the synthetic gene) is highlighted in red at 
positions: 66 in the full and 67 in the amplified active domain fragment. The first and last 
residues of the active domain fragment are highlighted in yellow. 
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Figure 11- Purified PCR products: lane 1-gene fragment for active domain of Cek1_Leu (1091 
bp), lane 2- gene fragment for active domain of Ras1_Ser (506 bp). 
 
The purified PCR products (gene fragments for active domain of Cek1_Leu and Ras1_Ser 
hereinafter referred as Cek1_Leu and Ras1_Ser) were double digested with NcoI and Acc65I 
restriction enzymes. These inserts (Cek1_Leu and Ras 1_Ser) were cloned into five pET 
(pETMBP, pETTrx, pETGb1, pETZ2 and pETNusA) expression vectors at the same NcoI and 
ACC65I sites. Therefore the vectors were prepared for ligation by double digestion with NcoI 
and Acc65I restriction enzymes. As a consequence of this double digestion the DNA sequence 
for GFP was cleaved from the pET expression vectors (see Figure 12). The double digested 
expression vectors were isolated and purified from agarose gel (see Figure 13). These pure 
linearised vectors were used to ligate the Cek1_Leu and Ras1_Ser inserts (prepared as 
described above). 
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Figure 12- Expression vectors: (A) double digestion (NcoI/Acc65I) of: lane 1- pETMBP (l6446 
bp), lane 2- pETTrx (5666 bp) and lane 3-pETGb1 (5510 bp); (B) schematic representation of 
plasmids showing the GFP position between NcoI and Acc65I restriction sites. 
 
 
Figure 13- Purified double digested vectors: lane 1- pETMBP, lane 2- pETTrx and lane 3- 
pETGb1. 
 
After ligation the constructs were transformed and the positive transformants were selected 
by plating onto LB-agar plates supplemented with 50 μg/ml Kan and grown overnight at 37 °C 
(see Figure 14). 
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Figure 14- Example for transformation results after ligation: C- control: transformation with 
ligation mixture containing only the linearised vector (no insert added) L- transformation with 
ligation mixture containing the linearised pETMBP and Cek1_Leu (insert) at a molar ratio of 
1:4. 
 
The plasmid DNA was isolated from the positive transformants and tested for the insert by 
double digestion with NcoI and Acc65I restriction enzymes (see Figure 15). As is shown in 
Figure 15 the double digestion separated the insert from the respect expression vector, 
confirming the success of the ligation reaction. 
 
Figure 15- Restriction analyses (NcoI/Acc65I) of positive transformants after ligation of 
Cek1_Leu in pETTrx (A: lane1- double digested, lane 2- no digestion) and pETMBP (B: lane 3- 
double digested, lane 4- no digestion. 
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Alternatively, the positive transformants, after ligation, were tested for the insert by 
performing a colony PCR (see Figure 16). Using this method the insert was amplified by PCR 
directly from bacterial colonies. 
 
 
Figure 16- Colony PCR after ligation of Ras1_Ser in pETGb1 vector. Ras1_Ser was successfully 
amplified by PCR from six different colonies.  
 
Finally the tested DNA plasmid samples were sent to Eurofins MWG Operon (Germany) for 
sequencing. The results were analyzed by performing alignments using ClustalW tool 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) (43). 
All of the five expression vectors (pETMBP, pETTrx, pETGb1, pETZ2 and pETNusA) were 
successfully cloned with Cek1_Leu and Ras1_Ser. Although, the cloning results presented 
above refer for cloning of Cek1_Leu and Ras1_Ser in two (pETMBP and pETTrx) or one 
(pETGb1) vectors respectively. These three constructs: pETTrx/Cek1_Leu, pETMBP/Cek1_ Leu 
and pETGb1/Ras1_Ser were used to express the proteins in large scale. 
The Cek1_Ser (serine variant for CUG codon) and Ras1_Leu (leucine variant for CUG codon) 
variants were prepared by site directed mutagenesis (SDM). The pETMBP/Cek1_Leu and 
pETGb1/Ras1_Ser constructs were used as templates in mutagenesis reaction. Using these 
templates with mutagenic primers (see section 3.1.8) the SDM resulted in pETMBP/Cek1_Ser 
and pETGb1_Ras1_Leu constructs.  The mutations were confirmed by sequencing results, 
which were aligned with the template DNA fragment (see Figure 16 -Figure 17). 
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Figure 17- Alignment performed between Cek1_Leu and the product of the SDM (Cek1_Ser) 
showing to have a serine for the leucine in the position 146. The proteins were aligned with 
clustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html) and the image was prepared with 
ESPRIPT (http://espript.ibcp.fr/ESPript/ESPript/). 
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Figure 18- Alignment performed between Ras1_Ser and the product of the SDM (Ras1_Leu) 
showing to have a leucine for the serine in the position 67. The proteins were aligned with 
clustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html) and the image was prepared with 
ESPRIPT (http://espript.ibcp.fr/ESPript/ESPript/). 
 
4.2. Protein expression and purification 
4.2.1. Cek1_Leu 
Expression tests were performed with following constructs: pETZ2/Cek1_Leu, 
pETGb1/Cek1_Leu, pETTrx/Cek1_Leu and pETMBP/Cek1_Leu. The results showed that 
Cek1_Leu in fusion with Z2 and Gb1 tags were expressed almost exclusively in inclusion bodies, 
while with Trx and MBP tags the soluble fraction of fusion proteins were observed. Expression 
tests with pETNusA/Cek1_Leu construct have not been carried out yet. 
 
4.2.1.1.  Trx_Cek1_Leu expression test 
Expression of soluble Cek1_Leu was assessed in fusion with Trx tag (pETTrx/Cek1_Leu 
construct) at analytical scale (50 mL cultures) using an incomplete factorial (IF) approach 
combining three E. coli strains [BL21Star(DE3), Origami2(DE3) and Rosetta(DE3)], three 
temperatures (20 °C, 25 °C and 30 °C) and two expression media (LB and 2YT). The expression 
patterns of 9 experiments (9 IF combinations, see Table 7 in section 3.2.2) were analysed by 
polyacrylamide gel electrophoresis. The results showed that at 25 °C and 30 °C Trx_Cek1_Leu 
was expressed almost exclusively in inclusion bodies (see Figure 19) while at 20 °C, although in 
small quantity, the expression of soluble form was observed in Rosetta(DE3) and 
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BL21Star(DE3) cells (see Figure 20). Furthermore the results also showed that the medium type 
(LB and 2YT) did not affect the expression of soluble Trx_Cek1_Leu (MW 54.79 kDa). 
 
 
Figure 19- 12.5 % SDS-PAGE analysis: Trx_Cek1 expression pattern in Rosetta(DE3) cells at 25 
°C and 30 °C. S- refers to the soluble and I- to the insoluble fractions. Similar expression 
patterns were obtained in BL21Star(DE3) and Origami2(DE3) cells. 
 
 
Figure 20-12.5 % SDS-PAGE analysis: Trx_Cek1 expression pattern in B- BL21Star(DE3),  O- 
Origami2(DE3) and R- Rosetta(DE3) 20 °C. S- refers to the soluble and I- to the insoluble 
fractions. 
  
 C. albicans Cek1 and Ras1: cloning, expression and purification 
 
 
 
46 
 
4.2.1.2. Trx_Cek1_Leu high-scale expression and purification 
The expression test patterns described above showed that the highest soluble Trx_Cek1_Leu 
(MW 54.79  Da) expression was o tained at 20˚C in E. coli Rosetta(DE3), when the cells were 
collected 18 hours after induction. These expression conditions were selected for large scale 
production of Trx _Cek1_Leu. The N-terminal His6-tagged Trx_Cek1_Leu was overexpressed in 
2000 ml of cell culture. After cell lysis, the soluble fraction was purified in two chromatography 
steps:  first an ion immobilized affinity chromatography (IMAC), which was followed by a 
preparative size exclusion chromatography (SEC). 
For the first purification step (IMAC), a column containing nickel (HisTrap HP column), which is 
known to bind histidine with high affinity, was used. To separate the His-tagged Trx_Cek1_Leu 
from other proteins, a step gradient of imidazole was used. A gel analysis of fractions collected 
during the chromatography is shown Figure 21. The load fraction corresponds to the sample 
that was loaded into the HisTrap column. The flow-through contains proteins, which do not 
show any binding to nickel. The 44 mM imidazole fraction (5% elution buffer) represents the 
proteins with low affinity to nickel. The Trx_Cek1_Leu was mostly eluted in the 92 mM 
imidazole fractions (15 % elution buffer, see Figure 21).  
 
 
Figure 21- 12.5 % SDS-PAGE analysis of different fractions collected during immobilized metal 
affinity chromatography. In the first lane, Precision Plus ProteinTM Standards molecular mass 
marker (Bio-Rad). “Ft” refers to the flow-through and “L” to the load. Fractions eluted with: 
lane1- 44 mM imidazole; lane 2 and 3 - 92 mM Imidazole; lane 4- 140 mM Imidazole and lane 
5- 212 mM imidazole.  
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Fractions containing the most pure and concentrated Trx_Cek1_Leu (lane 3 in the Figure 21) 
were further purified by preparative size exclusion chromatography using a Hiprep 26/60 
Sephacryl S-100 column. Figure 22A shows a typical elution profile for this SEC 
chromatography step. The first peak in this chromatogram corresponds to aggregates of 
Trx_Cek1_Leu (eluted in void volume of this column) and the second peak corresponds to 
monomeric Trx_Cek1_Leu (tested by analytical SEC). Fractions of this second peek were 
pooled, concentrated and analyzed on 12.5% SDS-PAGE (see Figure 22B). The SDS-PAGE gel 
showed that, after second purification step, the Trx_Cek1_Leu sample still contains some 
impurities. Furthermore the amount of this “pure” protein is quite low. From 2000 ml of 
bacterial broth, 2.2 mg of pure Trx_Cek1_Leu was obtained. Therefore, expression and 
purification of Cek1_Leu were further tested in fusion with another solubility tag (with MBP 
tag, see described below). 
 
 
Figure 22- (A) SEC Chromatogram and (B) 12.5 % SDS-PAGE analysis of concentrated 
Trx_Cek1_Leu, in the first lane: Precision Plus ProteinTM Standards molecular mass marker 
(Bio-Rad) 
 
4.2.1.3. MBP_Cek1_Leu high-scale expression and purification 
Expression of Cek1_Leu in fusion with MBP tag (pETMBP/Cek1_Leu) was first tested at 
analytical scale (50 ml) at two different expression temperature (20 °C, and 25 °C)  in E. coli 
strain BL21StarTM(DE3). The large scale expression of MBP_Cek1_Leu (84.98 kDa ) was 
performed at 20 °C for 18 hours (see Figure 23). 
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Figure 23- 12.5 % SDS-PAGE analysis: MBP_Cek1_Leu expression pattern in BL21StarTM(DE3) 
cells at 20 °C. S- refers to the soluble and I- to the insoluble fractions 
 
Purification of MBP_Cek1_Leu was performed using the same protocol as for purification of 
Trx_Cek1_Leu (described above) except that a Hiprep 26/60 Sephacryl S-200 (GE Healthcare) 
column was used for preparative SEC chromatography. In the first purification step 
MBP_Cek1_Leu was eluted from HisTrap column in all: 92 mM, 140 mM, 212 mM, 308 mM 
and 500 mM imidazole fractions (see Figure 24). Therefore a small (50 μl) sample from all 
these fractions was loaded to an analytical size exclusion column (Superose 12 10/300). The 
obtained analytical SEC chromatograms confirmed the MBP_Cek1_Leu eluted in 92 mM 
imidazole fractions contained less aggregates. Thus this fraction (lane 2 from Figure 24) was 
used to perform the second purification step, the preparative size exclusion chromatography. 
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Figure 24- 12.5 % SDS-PAGE analysis of different fractions collected during immobilized metal 
affinity chromatography. In the first lane, Precision Plus ProteinTM Standards molecular mass 
marker (Bio-Rad). “Ft” refers to the flow-through and “L” to the load. Fractions eluted with: 1- 
44 mM, 2- 92 Mm, 3- 140 mM, 4- 212 mM, 5- 308 mM and 6- 500 mM imidazole. 
 
The elution profile of this preparative SEC showed that, some of the protein was eluted in the 
void volume (first small peak of the chromatogram see Figure 25).  However the significant 
amount of the protein eluted at a volume compatible with monomeric MBP_Cek1_Leu (second 
peak of the SEC chromatogram see Figure 25). The oligomerization state of the protein was 
determined by analytical SEC (see section 4.4.1).The fractions composing the second peak of 
preparative SEC chromatogram were pooled and concentrated to a final concentration of 14.5 
mg/ml. This expression and purification protocol provided 8.5 mg pure soluble MBP_Cek1_Leu 
(see Figure 26) from 2000 ml bacterial broth. 
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Figure 25- SEC chromatogram. MBP_Cek1_Leu eluted in 92 mM imidazole from HisTrap was 
applied to a Hiprep 26/60 Sephacryl S-200 column.  
 
 
Figure 26- 12.5 % SDS-PAGE analysis of pure MBP_Cek1_Leu  
 
4.2.2. Ras1_Ser 
Expression of Ras1_Ser was tested in fusion with Trx (pETTrx/Ras1_Ser), MBP 
(pETMBP/Ras1_Leu) and Gb1 (pETGb1/Ras1_Ser) solubility tags. The expression tests and 
purification of Trx_Ras1_Ser and MBP_Ras1_Ser were performed by Zsuzsa Sárkány. The 
results of these experiments showed that Ras1_Ser in fusion with Trx tag forms soluble 
aggregates, while the soluble MBP_Ras1_Ser is monomeric (data not shown). As a 
consequence of these results it was decided to perform further expression tests with a smaller 
solubility tag as the Gb1. The results showed that Ras1_Ser in fusion with Gb1 was expressed 
in a significant amount in soluble form (detailed results described below). Expression tests with 
pETZ2/Ras1_Ser and pETNusA/Ras1_Ser constructs have not been carried out yet. 
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4.2.2.1. Gb1_Ras1_Ser high-scale expression and purification 
Expression of Ras1_Ser in fusion with Gb1 solubility tag (pETGb1/Ras1_Ser construct) was first 
tested at analytical scale (50 ml) at two different expression temperature (20 °C, and 25 °C) in 
E. coli strain BL21(DE3)pLysS. The large scale overexpression of Gb1_Ras1_Ser (27.780 kDa ) 
was performed at 25 °C for 4h (see Figure 27). Purification of Gb1_Ras_Ser was performed 
with the same two step purification protocol as used for purification of Trx_Cek1_Leu (see 
section 4.2.1.3). In the first purification step Gb1_Ras1_Ser was eluted from HisTrap column 
mainly in two 92 mM imidazole fractions (see Figure 28). These fractions were further purified 
by a preparative SEC on a Hiprep 26/60 Sephacryl S-200 column. In this purification step the 
aggregates, eluted in void volume, were separated from the monomeric Gb1_Ras1_Ser (see 
Figure 29). The oligomerization state of the protein was determined by analytical SEC (see 
section 4.4.1). The fractions composing the second peak of preparative SEC chromatogram 
were pooled and concentrated to a final concentration of 20 mg/ml. This expression and 
purification protocol provided 17 mg pure soluble Gb1_Ras1_Ser (see Figure 30) from 2000 ml 
bacterial broth. 
 
 
Figure 27- 12.5 % SDS-PAGE:  Gb1_Ras1_Ser expression pattern in BL21(DE3)PLysS cells. In the 
first lane, Precision Plus ProteinTM Standards molecular mass marker (Bio-Rad) (MS). S- refers 
to the soluble and I- to the insoluble fractions. 
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Figure 28- 12.5% SDS-PAGE analysis of different fractions eluted from Histrap and SEC. 
 
Figure 29- SEC chromatogram. Gb1_Ras1_Ser eluted in 92 mM imidazole from HisTrap was 
applied to a Hiprep 26/60 Sephacryl S-200 column. 
 
 
Figure 30- 12.5 % SDS-PAGE analysis of pure Gb1_Ras1_Ser. 
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4.3. TEV protease cleavage assay 
Purified MBP_Cek1_Leu was digested by in-house expressed and purified recombinant TEV 
protease in order to cleave the MBP tag together with histidine tag. Pilot digestions were 
performed using several enzyme/substrate molar ratios (1:2.5; 1:5; 1:10; 1:20; see Figure 31) 
at room temperature for 2h. The results, analyzed in 12.5% SDS-PAGE, show that in all four 
conditions (different enzyme/substrate molar ratios), the His6_ MBP tag was almost 
completely cleaved MBP_Cek1_Leu. Therefore for a scale-up of the process a molar ratio of 
1:20 (enzyme/ substrat) will be used. The His6_MBP tags and TEV (which possesses itself a 
His6Tag) will be separated from Cek1_Leu by a nickel affinity chromatography (HisTrap). 
Cek1_Leu should be collected in the flow-through. 
 
Figure 31- 12.5%SDS-Page analysis of TEV protease cleavage pilot experiments, performed 
with different enzyme/substrate molar ratios: 1- 0:1 (control); 2- 2- 1:2.5; 3- 1:5 4- 1:10; 5- 
1:20. 
 
4.4. Protein homogeneity/oligomerization state 
4.4.1. Analytical size-exclusion chromatography (SEC) 
The oligomerization state of the pure MBP_Cek1_Leu and Gb1_Ras1_Ser were assessed by 
analytical size exclusion chromatography. The pure MBP_Cek1_Leu and Gb1_Ras1_Ser were 
eluted from Superose 12 10/300 column as a single sharp peak with 11.95 and 12.96 ml of 
elution volumes (Ve) respectively, [see Figure 32A-B]. The superposed SEC chromatograms of 
standard molecular weight markers are shown in Figure 33A. The calibration curve for 
determination of molecular weights (see Figure 33B) was prepared as described in section 3.4 
(materials and methods). Using this calibration curve (Figure 33B) the molecular weights of 
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MBP_Cek1_Leu (Kav=0.28) and Gb1_Ras1_Ser (Kav=0.34) were found to be 89.2 and 31 kDa, 
respectively. These values are consistent with a monomer of MBP_Cek1_Leu (84.98kDa) and 
Gb1_Ras1_Ser (27.78) kDa. Thus, the analytical size exclusion chromatography confirmed the 
monomeric that both fusion proteins are likely to be monomeric in solution (MBP_Cek1_Leu 
and Gb1_Ras1_Ser). 
 
 
Figure 32- Analytical SEC chromatogram of (A) MBP_Cek1_Leu and (B) Gb1_Ras1_Ser 
 
Figure 33- Calibration of Superpose 12 10/300 column. (A) Two analytical SEC chromatograms 
of standard molecular weight markers are superposed, where 1 refers to aldolase (Molecular 
weight: 158 kDa; elution volume: 11.08 ml), 2 to albumin (67 kDa; 11.68 ml), 3 to ovalbumin 
(43 kDa; 12.45 ml), 4 to chymotrypsinogen A (25 kDa; 14.47 ml) and 5 to ribonuclease A (13.7 
kDa; 14.96 ml). (B) Calibration curve for determination of molecular weight by analytical SEC. 
 
4.4.2. Dynamic Light Scattering (DLS)  
The homogeneity of pure concentrated MBP_Cek1_Leu (14 mg/ml) and Gb1_Ras1_Ser (20 
mg/ml) were also assessed by DLS. Since the obtained DLS data (size distributions by intensity) 
show a substantial tail, the plots of the size distribution by intensity were converted to volume 
distribution (see Figure 34Figure 35) to get a more accurate interpretation of the data. The DLS 
 C. albicans Cek1 and Ras1: cloning, expression and purification 
 
 
 
55 
 
spectrums of MBP_Cek1_Leu and Gb1_Ras1_Ser showed one major population by size (see 
Figure 34 Figure 35) with a polydispersity (%Pd) of 18.8 and 18.5% respectively. As a rule of 
thumb, samples with % Pd <~20%, are considered to be monodisperse (see section 3.5). The RH 
(hydrodynamic radius) values were obtained from plots of size distribution as a function of 
volume. The MBP_Cek1_Leu and Gb1_Ras1_Ser RH values were found to be 4.3 and 2.43 nm 
respectively. These values were used to estimate the molecular weight (assuming a globular 
protein) using an empirical calibration graph developed by Malvern Instruments available in 
the Nano software (42). Accordingly, the molecular mass of MBP_Cek1_Leu and Gb1_Ras1_Ser 
were estimated to be 100 kDa and 26.6 kDa respectively. These values correspond to a 
monomeric form of MBP_Cek1_Leu (84.98kDa) and Gb1_Ras1_Ser (27.78 kDa). Thus, the DLS 
results (the pure MBP_Cek1_Leu and Gb1_Ras1_Ser samples are monodispers and 
monomeric) are consistent with the data obtained from analytical SEC (described above 
section 4.4.1). 
 
 
Figure 34- Distribution of hydrodynamic radii by volume from DLS spectrum for 
MBP_Cek1_Leu. 
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Figure 35- Distribution of hydrodynamic radii by volume from DLS spectrum for Gb1_Ras1_Ser. 
 
4.5. Crystallization screenings 
Crystallization trials were performed with the purified Gb1_Ras1_Ser protein (20 mg/mL) and 
MBP_Cek1_Leu (14.5 mg/ml) by vapor diffusion (sitting drop) techniques using the following 
crystallization kits:  Morpheus HT96 and PACT premierTM Crystallization Screen MD1-29 
(Molecular Dimensions Limited). In the majority of these crystallization conditions 
precipitation and phase separation was observed. Further crystallization screening for the 
preliminary crystallization conditions are going to be done with Ras1_Ser, Ras1_Leu, Cek1_Leu 
and Cek1_Ser after removal of the solubility tags.  
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5. Conclusions and future perspectives 
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In the present work, the catalytic domains of Cek1 (Leu variant for CUG codon) and Ras1 (Ser 
variant for CUG codon) were successfully cloned into five pET-derived expression vectors with 
variable 6 His-tagged N-terminus solubility tags (Gb1, NusA, MBP, Trx and Z2) cleavable with 
TEV protease. Moreover, the Ser variant (for CUG codon) of Cek1 and Leu variant (for CUG 
codon) of Ras1 were also prepared by site directed mutagenesis. 
Using an incomplete factorial approach, high level bacterial expression and purification 
protocols for the active domains of Cek1 (in fusion with MBP) and Ras1 (in fusion with Gb1) 
were developed. Furthermore, analytical size exclusion chromatography and dynamic light 
scattering results indicated that both recombinant fusion proteins are monomeric. To avoid 
any possible effect of the solubility tags on the crystallization and enzymatic activity of Cek1 
and Ras1 (for future studies), the His6_MBP and His6_Gb1 cleavage is being implemented in 
our expression and purification protocol. 
Crystallization screenings for both proteins are currently in progress, aiming the determination 
of their three-dimensional structures by X-ray crystallography. The structures of Ras1 and Cek1 
with Ser or Leu at CUG positions, together with a thorough analysis of their stability and 
function in vitro, will provide valuable insights into a possible strategic role of natural codon 
ambiguity in signaling pathways associated with morphogenesis and virulence.  
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Figure 36- Quality Assurance Documentation of the synthetic gene of Cek1_Leu (leucine 
variant for CUG codon position) purchased from Eurofins MWG Operon. 
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Figure 37- Quality Assurance Documentation of the synthetic gene of Ras1_Ser (serine variant 
for CUG codon position) purchased from Eurofins MWG Operon. 
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